XBiotech Inc.
XBIT Healthcare Biotechnology
XBiotech Inc.’s revenue for fiscal 2022 (year ended December 2022) was $4.0 million. In the quarter to June 2026, EPS fell 266.7% and free cash flow grew 25.3%, each against the same quarter a year earlier.
Follow XBIT
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
34.32 | 31.77 | 15.82 | 714.59 | 237.37 | 236.98 | 217.48 | 200.02 | 172.68 | 125.55 |
Receivables |
— | — | — | — | 85.75 | 8.95 | 1.76 | 0.94 | 0.86 | 0.36 |
Total current assets |
36.93 | 33.33 | 17.02 | 716.26 | 325.88 | 246.87 | 219.84 | 201.72 | 174.57 | 126.95 |
Property, Plant, Equpment (Net) |
10.14 | 29.64 | 27.33 | 25.17 | 27.34 | 28.31 | 26.26 | 24.90 | 24.53 | 23.13 |
Long-term receivables |
— | — | — | 75.00 | — | — | — | — | — | — |
Long Term Assets (Tax, Deferred) |
— | — | — | 0.44 | 0.53 | — | — | — | — | — |
Total non-current assets |
30.12 | 29.64 | 27.33 | 100.61 | 27.87 | 28.31 | 26.26 | 24.90 | 24.53 | 23.13 |
Total Assets |
67.05 | 62.97 | 44.35 | 816.88 | 353.74 | 275.18 | 246.10 | 226.62 | 199.09 | 150.08 |
Accounts Payable |
4.43 | 1.73 | 1.65 | 2.15 | 2.49 | 2.07 | 2.41 | 2.52 | 2.22 | 1.54 |
Accrued Expenses |
3.53 | 1.06 | 1.29 | 4.18 | 1.35 | 1.37 | 1.60 | 3.50 | 2.63 | 6.32 |
Current Part of Debt |
— | — | — | — | — | — | — | — | 10.25 | — |
Current Part of Taxes to Pay |
— | — | — | 49.36 | 0.14 | 0.01 | 0.06 | 0.08 | — | 0.08 |
Other current liabilities |
7.96 | 1.06 | 1.29 | 4.50 | — | — | — | — | — | — |
Total current liabilities |
7.96 | 2.79 | 2.94 | 60.19 | 3.98 | 3.45 | 4.07 | 6.10 | 15.11 | 7.93 |
Long Term Tax Liability (Deferred) |
— | — | — | (0.44) | (0.53) | 0.87 | 0.06 | — | — | 0.01 |
Non-current Liabilities (Other) |
0.02 | 0.02 | 0.00 | 1.06 | 1.12 | 1.47 | 1.64 | 1.67 | 1.72 | 1.80 |
Total non-current liabilities |
0.02 | 0.02 | 0.00 | 1.06 | 1.12 | 2.34 | 1.64 | 1.67 | 1.72 | 1.80 |
Total liabilities |
7.99 | 2.81 | 2.95 | 61.25 | 5.11 | 5.79 | 5.70 | 7.77 | 16.83 | 9.73 |
Common Stock (Net) |
242.42 | 277.49 | 279.35 | 324.81 | 249.81 | 262.26 | 267.33 | 271.15 | 273.11 | 276.73 |
Retained Earnings |
(183.41) | (216.56) | (237.70) | 430.93 | 97.57 | 5.15 | (27.75) | (52.31) | (90.84) | (136.38) |
Common Equity (Total) |
59.06 | 60.16 | 41.40 | 755.63 | 348.64 | 269.39 | 240.40 | 218.85 | 182.27 | 140.35 |
Shareholders Equity (Total) |
59.06 | 60.16 | 41.40 | 755.63 | 348.64 | 269.39 | 240.40 | 218.85 | 182.27 | 140.35 |
Shareholders Equity and Liabilities (Total) |
67.05 | 62.97 | 44.35 | 816.88 | 353.74 | 275.18 | 246.10 | 226.62 | 199.09 | 150.08 |
Shares (Common) |
32.63 | 35.44 | 35.90 | 41.52 | 29.30 | 30.44 | 30.44 | 30.44 | 30.49 | 30.49 |
Shareholders Equity (Tangible) |
59.06 | 60.16 | 41.40 | 755.63 | 348.64 | 269.39 | 240.40 | 218.85 | 182.27 | 140.35 |
Net Debt |
(34.32) | (31.77) | (15.82) | (714.59) | (237.37) | (236.98) | (217.48) | (200.02) | (162.43) | (125.55) |
Total Debt |
— | — | — | — | — | — | — | — | 10.25 | — |